Research Paper Volume 15, Issue 19 pp 10253—10271
Development of a prognostic model based on anoikis-related genes for predicting clinical prognosis and immunotherapy of hepatocellular carcinoma
Figure 4. Risk model development based on prognostic ARGs. (A, B) Subgroup analysis of HCC risk based on prognostic ARGs. (C) Unsupervised PCA analysis. (D) Clinical survival outcome assessment of HCC risk subgroups. (E) Time-dependent ROC curve analysis. (F) Risk score distribution of HCC molecular subtypes. (G) Association analysis of HCC molecular subtypes, risk subgroups and clinical survival outcomes.